Total Payments
$2,016
2024 Payments
$167.72
Companies
17
Transactions
105
Medicare Patients
8,567
Medicare Billing
$861,580
Payment Breakdown by Category
Food & Beverage$1,751 (86.9%)
Education$264.97 (13.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,751 | 102 | 86.9% |
| Education | $264.97 | 3 | 13.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $479.20 | 15 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $407.58 | 29 | $0 (2023) |
| GENZYME CORPORATION | $208.82 | 9 | $0 (2024) |
| LEO Pharma Inc. | $195.21 | 10 | $0 (2024) |
| ABBVIE INC. | $185.21 | 12 | $0 (2022) |
| Lilly USA, LLC | $160.36 | 11 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $98.62 | 2 | $0 (2021) |
| Sun Pharmaceutical Industries Inc. | $80.81 | 4 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $28.41 | 2 | $0 (2019) |
| Incyte Corporation | $27.48 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $167.72 | 8 | GENZYME CORPORATION ($88.67) |
| 2023 | $329.93 | 19 | Novartis Pharmaceuticals Corporation ($104.14) |
| 2022 | $316.96 | 14 | LEO Pharma Inc. ($133.19) |
| 2021 | $641.85 | 29 | Janssen Biotech, Inc. ($251.20) |
| 2020 | $197.05 | 12 | GENZYME CORPORATION ($79.40) |
| 2019 | $159.44 | 10 | Novartis Pharmaceuticals Corporation ($35.79) |
| 2018 | $117.62 | 7 | Novartis Pharmaceuticals Corporation ($56.84) |
| 2017 | $85.67 | 6 | Janssen Biotech, Inc. ($31.88) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Immunology | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: Immunology | ||||||
| 08/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.18 | General |
| Category: Immunology | ||||||
| 05/29/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Inflammation | ||||||
| 05/22/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: DERMATOLOGY | ||||||
| 05/09/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: DERMATOLOGY | ||||||
| 05/07/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Immunology | ||||||
| 03/25/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Dermatology | ||||||
| 09/13/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Immunology | ||||||
| 09/06/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Immunology | ||||||
| 08/21/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Dermatology | ||||||
| 07/13/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Dermatology | ||||||
| 06/19/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Dermatology | ||||||
| 05/11/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Immunology | ||||||
| 05/02/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: DERMATOLOGY | ||||||
| 04/17/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Dermatology | ||||||
| 04/11/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Immunology | ||||||
| 04/03/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Dermatology | ||||||
| 03/21/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Dermatology | ||||||
| 03/21/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Immunology | ||||||
| 02/06/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Dermatology | ||||||
| 02/06/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Dermatology | ||||||
| 01/18/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Dermatology | ||||||
| 01/17/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.48 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,582 | 2,153 | $595,890 | $174,472 |
| 2022 | 19 | 1,638 | 2,531 | $577,583 | $176,995 |
| 2021 | 18 | 2,175 | 3,480 | $707,605 | $211,585 |
| 2020 | 20 | 3,172 | 6,144 | $1.1M | $298,528 |
Total Patients
8,567
Total Services
14,308
Medicare Billing
$861,580
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 484 | 642 | $175,092 | $55,515 | 31.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 203 | 228 | $94,164 | $28,263 | 30.0% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 170 | 184 | $56,672 | $16,091 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 145 | 145 | $55,535 | $15,805 | 28.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 119 | 123 | $31,734 | $9,780 | 30.8% |
| 11643 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 37 | 40 | $35,320 | $9,332 | 26.4% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 14 | 17 | $27,251 | $7,573 | 27.8% |
| 11403 | Removal of noncancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 34 | 42 | $18,480 | $5,311 | 28.7% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 21 | 22 | $15,972 | $4,484 | 28.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 104 | 108 | $20,520 | $3,607 | 17.6% |
| 11623 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 13 | 15 | $10,605 | $2,998 | 28.3% |
| 11443 | Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 16 | 18 | $9,414 | $2,845 | 30.2% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 13 | 15 | $9,915 | $2,500 | 25.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 35 | 38 | $7,980 | $2,244 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 32 | $5,312 | $1,988 | 37.4% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 19 | $7,315 | $1,939 | 26.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 78 | 358 | $6,444 | $1,802 | 28.0% |
| 11423 | Removal of noncancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 12 | 12 | $5,640 | $1,753 | 31.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 14 | 15 | $1,725 | $577.09 | 33.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 21 | 80 | $800.00 | $62.71 | 7.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 391 | 501 | $124,248 | $45,474 | 36.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 154 | 174 | $71,862 | $22,543 | 31.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 126 | 126 | $48,258 | $14,166 | 29.4% |
| G6003 | Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: up to 5 mev | Office | 2022 | 15 | 110 | $27,352 | $12,483 | 45.6% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 120 | 129 | $39,732 | $11,446 | 28.8% |
About Dr. T Warthan, MD
Dr. T Warthan, MD is a Dermatology healthcare provider based in Nacogdoches, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679647317.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. T Warthan, MD has received a total of $2,016 in payments from pharmaceutical and medical device companies, with $167.72 received in 2024. These payments were reported across 105 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,751).
As a Medicare-enrolled provider, Warthan has provided services to 8,567 Medicare beneficiaries, totaling 14,308 services with total Medicare billing of $861,580. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Nacogdoches, TX
- Active Since 11/17/2006
- Last Updated 03/18/2014
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679647317
Products in Payments
- TREMFYA (Drug) $434.06
- COSENTYX (Biological) $303.44
- DUPIXENT (Biological) $233.10
- ADBRY (Biological) $195.21
- TALTZ (Drug) $160.36
- COSENTYX (Drug) $104.14
- SKYRIZI (Biological) $101.71
- HUMIRA (Biological) $48.21
- Winlevi (Drug) $44.39
- ILUMYA (Biological) $36.42
- STELARA (Biological) $31.88
- Otezla (Drug) $30.58
- SIVEXTRO (Drug) $28.41
- OPZELURA (Drug) $27.48
- EUCRISA (Drug) $26.60
- XEOMIN (Biological) $23.62
- VTAMA (Drug) $19.04
- Humira (Biological) $16.25
- Tremfya (Drug) $13.26
- ACZONE (Drug) $12.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.